Activities of new quinoline derivatives against genital pathogens.
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroIn vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.Biotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tractsIn vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.A review of the antimicrobial activity of the fluoroquinolones.Quinolone antibacterial agents for the treatment of genitourinary tract infections.In-vitro activity of ofloxacin against Chlamydia trachomatis.In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.Antichlamydial activity of ofloxacin.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Norfloxacin: clinical pharmacology and clinical use.Effect of ofloxacin on Treponema pallidum in incubating experimental syphilis.In vitro activity of 14 antimicrobial agents against Neisseria gonorrhoeae from Spain.Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae.The place of quinolones in antibacterial therapy in hospitals.
P2860
Q24670241-0A606F8D-5DF2-49D4-A6AE-B1AB911DD6F7Q33744065-930FC9E6-07F7-4CA6-8533-CB7EFE253BDCQ33931694-7DDAD655-6B0B-464B-90EA-648E018B694EQ34681907-77A8FF23-DE60-4827-99A4-011151793FDDQ34687048-B3677B6B-3E2B-4A7E-AA58-44D3136D4C8FQ35243711-2483755E-10B7-4475-A5AD-71D0BD216761Q35246755-788739AF-6AB1-4B74-B83E-3B52D9DDBAA2Q35564364-71EAACB6-9659-434D-9AD4-157641D54E01Q35575297-536AE93B-2CD4-40DF-8109-374569A9A4A9Q35653982-DFF031CC-0DA0-4771-9144-D32FF897DBB9Q35843623-82BAEA76-A8CB-4538-A200-304915EECF9AQ37834318-407B2440-892B-4042-87D1-0BF421D4503CQ37897445-C9F43907-BAE3-4C8F-B527-95F767D194A9Q37897912-FB20A542-F014-49C8-89CF-93875EDD7CBCQ37899020-2CEDA5EE-5747-4FCB-B167-E9074848D1C1Q37899417-10B01D29-667B-4B67-8728-772C089004ADQ37902437-403D6625-9033-41D1-99C4-4949AE5B74C4Q37903603-D1403532-7D1F-459C-B6C4-3600A947319BQ39214819-85E01452-D598-4F29-A4A8-0C54D42295D9Q39681144-49D410A1-1F96-4E99-A0E7-C8AB49578AF6Q42946079-80CB78D5-9C93-43ED-917E-632F9DF8CD9AQ42946086-7B79AF23-F7A5-4379-A7BE-EE44A3DAEEC1Q45171352-10F83456-485B-4FD3-9CF9-51AFA5261B66Q54432495-79B16844-84D1-4085-9466-0671F51989CD
P2860
Activities of new quinoline derivatives against genital pathogens.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Activities of new quinoline derivatives against genital pathogens.
@ast
Activities of new quinoline derivatives against genital pathogens.
@en
type
label
Activities of new quinoline derivatives against genital pathogens.
@ast
Activities of new quinoline derivatives against genital pathogens.
@en
prefLabel
Activities of new quinoline derivatives against genital pathogens.
@ast
Activities of new quinoline derivatives against genital pathogens.
@en
P2093
P2860
P356
P1476
Activities of new quinoline derivatives against genital pathogens.
@en
P2093
Caballero MC
Palomares JC
de Miguel C
P2860
P356
10.1128/AAC.27.1.76
P407
P577
1985-01-01T00:00:00Z